Melanoma-associated antigens recognized by cytotoxic T lymphocytes

APMIS

Volumn 106, Issue 7, 1998, Pages 665-679

  Kirkin, Alexei F ^a   Dzhandzhugazyan, Karine ^a   Zeuthen, Jesper ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cytotoxic T lymphocytes; Immunogenicity; Immunotherapy; Melanoma associated antigens

Indexed keywords

MELANOMA ANTIGEN;

CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOTHERAPY; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; REVIEW; TUMOR CELL; TUMOR REGRESSION;

EID: 0031878005     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00210.x     Document Type: Review

References (92)

1. Anichini, A., Maccalli, C., Mortarini, R., Salvi, S., Mazzocchi, A., Squarcina, P., Herlyn, M. & Parmiani, G.: Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 177: 989-998, 1993.
2. Anichini, A., Mortarini, R., Maccalli, C., Squarcina, P., Fleischhauer, K., Mascheroni, L. & Parmiani, G.: Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. J. Immunol. 156: 208-217, 1996.
3. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J. & Figdor, C. G.: Melanocyte lineage-specific antigen Gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179: 1005-1009, 1994.
4. Barker, C. F. & Billingham, R. E.: Immunologically privileged sites. Adv. Immunol. 25: 1-54, 1977.
5. Bartkova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J. & Bartek, J.: The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer. Res. 56: 5475-5483, 1996.
6. Boël, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J. C., Coulie, P., Boon, T. & van der Bruggen, P.: BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2: 167-175, 1995.
7. Bouchard, B., Fuller, B. B., Vijayasaradhi, S. & Houghton, A. N.: Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med. 769: 2029-2042, 1989.
8. Brasseur, F., Rimoldi, D., Liénard, D., Lethé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., Vacca, A., Conese, M., Lahaye, T., Degiovanni, G., Deraemaecker, R., Beauduin, M., Sastre, X., Salomon, E., Dréno, B., Jäger, E., Knuth, A., Chevreau, C., Suciu, S., Lachapelle, J. M., Pouillart, P., Parmiani, G., Lejeune, F., Cerottini, J. C., Boon, T. & Marchand, M.: Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer 63: 375-380, 1995.
9. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P. & Boon, T.: The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495, 1993.
10. Brichard, V. G., Herman, J., Van Pel, A., Wildmann, C., Gaugler, B., Wölfel, T., Boon, T. & Lethé, B.: A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur. J. Immunol. 26: 224-230, 1996.
11. Castelli, C., Storkus, W. J., Maeurer, M. J., Martin, D. M., Huang, E. C., Pramanik, B. N., Nagabhushan, T. L., Parmiani, G. & Lotze, M. T.: Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8(+) cytotoxic T lymphocytes. J. Exp. Med. 181: 363-368, 1995.
12. Chambost, H., Brasseur, F., Coulie, P., De Plaen, E., Stoppa, A. M., Baume, D., Mannoni, P., Boon, T., Maraninchi, D. & Olive, D.: A tumour-associated antigen expression in human haematological malignancies. Br. J. Haematol. 84: 524-526, 1993.
13. Chen, Y. T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M. & Old, L. J.: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94: 1914-1918, 1997.
14. Cormier, J. N., Salgaller, M. L., Prevette, T., Barracchini, K. C., Rivoltini, L., Restifo, N. P., Rosenberg, S. A. & Marincola, F. M.: Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. Cancer J. Sci. Am. 3: 37-44. 1997.
15. Coulie, P. G., Brichard, K., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J.P., Renauld, J. C. & Boon, T.: A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180: 35-42, 1994.
16. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M. & Boon, T.: A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 92: 7976-7980, 1995.
17. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F. & Slingluff, C. L. Jr.: Identification of a peptide recognized by five melanomaspecific human cytotoxic T cell lines. Science 264: 716-719, 1994.
18. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. P., de Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W. & Boon, T.: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369, 1994.
19. de Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F. & Boon, T.: The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA 93: 7149-7153, 1996.
20. de Smet, C., Martelange, V., Lucas, S., Brasseur, F., Lurquin, C. & Boon, T.: Identification of human testis-specific transcripts and analysis of their expression in tumor cells. Biochem. Biophys. Res. Commun. 241: 653-657, 1997.
21. Dick, L. R., Aldrich, C., Jameson, S. C., Moomaw, C. R., Pramanick, B. C., Doyle, C. K., DeMartino, G. N., Bevan, M. J., Forman, J. M. & Slaughter, C. A.: Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152: 3884-3894, 1994.
22. Eura, M., Ogi, K., Chikamatsu, K., Lee, K. D., Nakano, K., Masuyama, K., Itoh, K. & Ishikawa, T.: Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas. Int. J. Cancer 64: 304-308, 1995.
23. Gamier, J., Gibrat, J. F. & Robson, B.: GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol. 266: 540-553, 1996.
24. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F. & Boon, T.: Human gene Mage-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179: 921-930, 1994.
25. Goldberg, A. L. & Rock, K. L.: Proteolysis, proteasomes and antigen presentation. Nature 357: 375-379, 1992.
26. Guilloux, Y., Lucas, S., Brichard, V. G., Van Pel, A., Viret, C., De Plaen, E., Brasseur, F., Lethé, B., Jotereau, F. & Boon, T.: A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183: 1173-1183, 1996.
27. Gure, A. O., Tureci, O., Sahin, U., Tsang, S., Scanlan, M. J., Jager, E., Knuth, A., Pfreundschuh, M., Old, L. J. & Chen, Y. T.: SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer 72: 965-971, 1997.
28. Herman, J., van der Bruggen, P., Luescher, I. F., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T. & Coulie, P. G.: A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics 43: 377-383, 1996.
29. INK4A characterize the major types of hematological malignancies. Cancer Res. 57: 837-841, 1997.
30. Ikeda, H., Lethé, B., Lehmann, F., van Baren, N., Baurain, J. F., de Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. & Coulie, P. G.: Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6: 199-208, 1997.
31. Jurk, M., Kremmer, E., Schwarz, U., Forster, R. & Winnacker, E. L.: MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus. Int. J. Cancer 75: 762-766, 1998.
32. Jäger, E., Chen, Y.-T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jäger, D., Arand, M., Wada, H., Noguchi, Y., Stocken, E., Old, L. J. & Knuth, A.: Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187: 265-270, 1998.
33. Kang, X. Q., Kawakami, Y., El-Gamil, M., Wang, R. F., Sakaguchi, K., Yannelli, J. R., Appella, E., Rosenberg, S. A. & Rabbins, P. F.: Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol. 155: 1343-1348, 1995.
34. Katano, M., Nakumura, M., Morisaki, T. & Fujimoto, K.: Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease. J. Surg. Oncol. 64: 195-201, 1997.
35. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T. & Rosenberg, S. A.: Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91: 3515-3519, 1994.
36. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T. & Rosenberg, S. A.: Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91: 6458-6462, 1994.
37. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X. Q., Southwood, S., Robbins, P. F., Sette, A., Appella, E. & Rosenberg, S. A.: Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154: 3961-3968, 1995.
38. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E. & Rosenberg, S. A.: Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180: 347-352, 1994.
39. Kawakami, Y. & Rosenberg, S. A.: T-cell recognition of self peptides as tumor rejection antigens. Immunol. Res. 15: 179-190, 1996.
40. Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C., Colella, T. A., Shabanowitz, J. A., Hunt, D. F., Engelhard, V. H. & Slingluff, C. L. J.: Human melanoma patients recognize an HLA-A!-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. J. Immunol. 160: 2099-2106, 1998.
41. Kocher, T., Schultzthater, E., Gudat, F., Schaefer, C., Casorati, G., Juretic, A., Willimann, T., Harder, F., Heberer, M. & Spagnoli, G. C.: Identification and intracellular location of MAGE-3 gene product. Cancer Res. 55: 2236-2239, 1995.
42. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T. & Coulie, P. G.: Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25: 340-347, 1995.
43. Lucas, S., de Smet, C., Arden, K. C., Viars, C. S., Lethe, B., Lurquin, C. & Boon, T.: Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 58: 743-752, 1998.
44. Lurquin, C., de Smet, C., Brasseur, F., Muscatelli, F., Martelange, V., De Plaen, E., Brasseur, R., Monaco, A. P. & Boon, T.: Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46: 397-408, 1997.
45. Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J. L., Laurent, C., Naeyaert, J. M., Plagne, R., Deraemaeker, R., Knuth, A., Jäger, E., Brasseur, F., Herman, J., Coulie, P. G. & Boon, T.: Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer 63: 883-885, 1995.
46. Margolin, J. F., Friedman, J. R., Meyer, W. K., Vissing, H., Thiesen, H. J. & Rauscher, F. J.: Krüppel-associated boxes are potent transcriptional repression domains. Proc. Natl. Acad. Sci. USA 91: 4509-4513, 1994.
47. Mulcahy, K. A., Rimoldi, D., Brasseur, F., Rodgers, S., Liénard, D., Marchand, M., Rennie, I. G., Murray, A. K., McIntyre, C. A., Platts, K. E., Leyvraz, S., Boon, T. & Rees, R. C.: Infrequent expression of the MAGE gene family in uveal melanomas. Int. J. Cancer 66: 738-742, 1996.
48. Niedermann, G., Butz, S., Ihlenfeldt, H. G., Grimm, R., Lucchiari, M., Hoschützky, H., Jung, G., Maier, B. & Eichmann, K.: Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2: 289-299, 1995.
49. Nonacs, R., Humborg, C., Tam, J. P. & Steinman, R. M.: Mechanism of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J. Exp. Med. 176: 519-529, 1992.
50. Ohta, M., Berd, D., Shimizu, M., Nagai, H., Cotticelli, M.-G., Mastrangelo, M., Shields, J. A., Shields, C. L., Croce, C. M. & Huebner, K.: Deletion mapping of chromosome region 9p21-022 surrounding the CDKN2 locus in melanoma. Int. J. Cancer 65: 762-767, 1997.
51. Patard, J. J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., Francois, P., Abi-Aad, A., Van Cangh, P., Abbou, C. C., Chopin, D. & Boon, T.: Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer 64: 60-64, 1995.
52. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, Y. R., Appella, E. & Rosenberg, S. A.: Induction of tumorreactive CTL from peripheral blood and tumorinfiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154: 2257-2265, 1995.
53. Robbins, P. F., El-Gamil, M., Kawakami, Y. & Rosenberg, S. A.: Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54: 3124-3126, 1994.
54. Robbins, P. F., El-Gamil, M., Li, Y. F., Fitzgerald, E. B., Kawakami, Y. & Rosenberg, S. A.: The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J. Immunol. 759: 303-308, 1997.
55. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E. & Rosenberg, S. A.: A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183: 1185-1192, 1996.
56. Robbins, P. F., El-Gamil, M., Li, Y. F., Topalian, S. L., Rivoltini, L., Sakaguchi, K., Appella, E., Kawakami, Y. & Rosenberg, S. A.: Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J. Immunol. 154: 5944-5950, 1995.
57. Rogers, S., Wells, R. & Rechsteiner, M.: Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368, 1986.
58. Romero, P., Gervois, N., Schneider, J., Escobar, P., Valmori, D., Pannetier, C., Steinle, A., Wölfel, T., Lienard, D., Brichard, V., Van Pel, A., Jotereau, F. & Cerottini, J. C.: Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. J. Immunol. 759: 2366-2374, 1997.
59. Sahin, U., Türeci, Ö., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I. & Pfreundschuh, M.: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92: 11810-11813, 1995.
60. Salgaller, M. L., Afshar, A., Marincola, F. M., Rivoltini, L., Kawakami, Y. & Rosenberg, S. A.: Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res. 55: 4972-4979, 1995.
61. Schultzthater, E., Juretic, A., Dellabona, P., Lusher, U., Siegrist, W., Harder, F., Heberer, M., Zuber, M. & Spagnoli, G. C.: MAGE-1 gene product is a cytoplasmic protein. Int. J. Cancer 59: 435-439, 1994.
62. Shichijo, S., Tsunosue, R., Masuoka, K., Natori, H., Tamai, M., Miyajima, J., Sagawa, K. & Itoh, K.: Expression of the MAGE gene family in human lymphocytic leukemia. Cancer Immunol. Immunother. 41: 95-103, 1995.
63. Sidney, J., Grey, H. M., Kubo, R. T. & Sette, A.: Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17: 261-266, 1996.
64. Skipper, J. C. A., Hendrickson, R. C., Gulden, P. H., Brichard, V., Van Pel, A., Chen, Y., Shabanowitz, J., Wölfel, T., Slingluff, C. L. Jr., Boon, T., Hunt, D. F. & Engelhard, V. H.: An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183: 527-534, 1996.
65. Skipper, J. C. A., Kittlesen, D. J., Hendrickson, R. C., Deacon, D. D., Harthun, N. L., Wagner, S. N., Hunt, D. F., Engelhard, V. H. & Slingluff, C. L.: Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. J. Immunol. 157: 5027-5033, 1996.
66. Spagnoli, G. C., Schaefer, C., Willimann, T. E., Kocher, T., Amoroso, A., Juretic, A., Zuber, M., Luscher, U., Harder, F. & Heberer, M.: Peptide-specific CTL in tumor-infiltrating lymphocytes from metastatic melanomas expressing MART-I/ Melan-A, gp100 and Tyrosinase genes: A study in an unselected group of HLA-A2.1-positive patients. Int. J. Cancer 64: 309-315, 1995.
67. Stevens, E. J., Jacknin, L. Robbins, P. F., Kawakami, Y., El-Gamil, M., Rosenberg, S. A. & Yannelli, J. R.: Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. J. Immunol. 154: 762-771, 1995.
68. Takahashi, K., Shiehijo, S., Noguchi, M., Hirohata, M. & Itoh, K.: Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 55: 3478-3482, 1995.
69. Tanaka, F., Fujie, T., Tahara, K., Mori, M., Takesako, K., Sette, A., Celis, E. & Akiyoshi, T.: Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res. 57: 4465-4468, 1997.
70. Tomita, Y., Kimura, M., Tanikawa, T., Nishiyama, T., Morishita, H., Takeda, M., Fujiwara, M. & Sato, S.: Immunohistochemical detection of intracellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex class I antigens in seminoma. J. Urol. 149: 659-663, 1993.
71. Topalian, S. L., Solomon, D., Avis, F. P., Chang, A. E., Freerksen, D. L., Linehan, W. M., Lotze, M., Robertson, C. N., Seipp, C. A., Simon, P., Simpson, C. G. & Rosenberg, S. A.: Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin 2. J. Clin. Oncol. 6: 839-853, 1988.
72. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A. & Boon, T.: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-Al by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176: 1453-1457, 1992.
73. Türeci, Ö., Sahin, U., Schobert, I., Kuslowski, M., Schmitt, H., Schild, H. J., Stenner, F., Seitz, G., Rammensee, H. G. & Pfreundschuh, M.: The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56: 4766-4772, 1996.
74. Uetsuki, T., Takagi, K., Sugiura, H. & Yoshikawa, K.: Structure and expression of the mouse necdin gene. Identification of a postmitotic neuron-restrictive core promoter. J. Biol. Chem. 271: 918-924, 1996.
75. Valmori, D., Fonteneau, J. F., Lizana, C. M., Gervois, N., Lienard, D., Rimoldi, D., Jongeneel, V., Jotereau, F., Cerottini, J. C. & Romero, P.: Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 160: 1750-1758, 1998.
76. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S. & Boon, T.: A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182: 689-698, 1995.
77. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., de Smet, C., Traversari, C., Townsend, A. & Boon, T.: A peptide encoded by human gene MAGE-3 and presented by HLAA2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24: 3038-3043, 1994.
78. van der Bruggen, P., Szikora, J. P., Boël, P., Wildmann, C., Somville, M., Sensi, M. & Boon, T.: Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw* 1601. Eur. J. Immunol. 24: 2134-2140, 1994.
79. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. & Boon, T.: A gene encoding an antigen recognized by cytolytic T on a human melanoma. Science 254: 1643-1647, 1991.
80. van Elsas, A., van der Burg, S. H., Van der Minne, C. E., Borghi, M., Mourer, J. S., Melief, C. J. M. & Schrier, P. I.: Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/ MART-1 self antigen. Eur. J. Immunol. 26: 1683-1689, 1996.
81. Van Pel, A., van der Bruggen, P., Coulie, P. G., Brichard, V. G., Lethe, B., Van den Eynde, B., Uyttenhove, C., Renauld, J. C. & Boon, T.: Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol.Rev. 145: 229-250, 1995.
82. Visseren, M. J., van der Burg, S. H., van der Voort, E. I., Brandt, R. M., Schrier, P. I., van der Bruggen, P., Boon, T., Melief, C. J. & Kast, W. M.: Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product. Int. J. Cancer 73: 125-130, 1997.
83. Walker, K. K. & Levine, A. J.: Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA 93: 15335-15340, 1996.
84. Wang, R. F., Appella, E., Kawakami, Y., Kang, X. Q. & Rosenberg, S. A.: Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184: 2207-2216, 1996.
85. Wang, R. F., Johnston, S. L., Southwood, S., Sette, A. & Rosenberg, S. A.: Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33. J. Immunol. 160: 890-897, 1998.
86. Wang, R. F., Parkhurst, M. R., Kawakami, Y., Robbins, P. F. & Rosenberg, S. A.: Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183: 1131-1140, 1996.
87. Wang, R. F., Robbins, P. F., Kawakami, Y., Kang, X. Q. & Rosenberg, S. A.: Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181: 799-804, 1995.
88. Weber, J., Salgaller, M., Samid, D., Johnson, B., Herlyn, M., Lassam, N., Treisman, J. & Rosenberg, S. A.: Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res. 54: 1766-1771, 1994.
89. Wenzel, T. & Baumeister, W.: Conformational constraints in protein degradation by the 20S proteasome. Nat. Struct. Biol. 2: 199-204, 1997.
90. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269: 1281-1284, 1995.
91. Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Büschenfelde, K.H. & Boon, T.: Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24: 759-764, 1994.
92. Yamashita, N., Ishibashi, H., Hayashida, K., Kudo, J., Takenaka, K., Itoh, K. & Niho, Y.: High frequency of the MAGE-1 gene expression in hepatocellular carcinoma. Hepatology 24: 1437-1440, 1996.